Skip to content

Beyond cholesterol: statins may protect heart health in people with HIV through multiple mechanisms

Professor Steven Grinspoon at a media briefing at CROI 2025, talking into a microphone.

Coronary artery disease uncommon in people with HIV in Uganda

Dr Mark Siedner presenting at CROI 2025. He is standing behind a lectern talking into a microphone.

Why aren’t more people with HIV accessing doxyPEP?

A person in a grey tshirt holding a white pill.

HIV acquisition in women with good adherence to TAF/FTC PrEP is rare

A bottle of blue pills is spilling out onto a table.

New long-acting HIV drugs show promising early results

Dr Luise Rogg (who presented the VH-184 study) at a media briefing at CROI 2025. Luise is talking into a microphone.

Broadly neutralising antibody N6LS could be part of long-acting HIV treatment

Dr Babafemi Taiwo talking into a microphone at a media briefing at CROI 2025.

Injectable PrEP use leads to zero new HIV infections among gay, trans and non-binary Brazilians

Dr Beatriz Grinsztejn at a media briefing at CROI 2025. She is talking into a microphone.

Once-yearly PrEP moves closer: experimental lenacapavir formulations show promise

Dr Renu Singh at a media birefing at CROI 2025.

Positive interactions with healthcare workers improve HIV care retention in Malawi and Zambia

Silas Odiya of Rakai Health Sciences at a media briefing at CROI 2025.